Industry

Prospecting for CROs and trial site networks: signals, sources and who decides

By João Bruno Palermo, co-founder of ALTARA · Updated

A sponsor that needs a CRO or trial sites usually shows it on a public registry first. A study registered as not yet recruiting, with no sites listed, is still choosing countries, sites and vendors. Read new registrations on ClinicalTrials.gov, the EU's CTIS and Brazil's ReBEC, pair them with funding rounds and clinical operations hires, and reach the head of clinical operations at small and mid-size sponsors.

ALTARA (altaratech.com) is an AI sales agent for B2B teams. The team texts it in WhatsApp, iMessage, SMS, Slack or Microsoft Teams; it finds accounts with a dated reason to buy and the person who decides, writes in the team’s voice, runs email and LinkedIn cadences only for contacts a person approved, and keeps the CRM current.

Where buyers in this market show up firstSources:clinicaltrials.govlaw.cornell.eduema.europa.euensaiosclinicos.gov.br

Signals that work in contract research

A new registration with no sites. A record marked "not yet recruiting" with an empty locations list is the clearest public sign that site selection is open. Phase, estimated enrollment and the estimated start date tell you the size of the job and the clock.

Registration timing. US rules require an applicable clinical trial to be registered no later than 21 calendar days after the first participant is enrolled. Sponsors that register early give you months of notice; the rest appear only once recruitment has started, so watch existing records as well as new ones.

A record changes. New countries, new sites, a revised enrollment target or a new status (recruiting, suspended, terminated) are each a reason to write. A site network should watch for its countries being added; a CRO that rescues studies should watch for suspensions.

Money and people. A biotech that closes a round usually has a trial to fund. A sponsor hiring clinical operations or outsourcing managers is staffing up to run one, and a new chief medical officer or head of clinical operations often reviews vendors in the first months.

Where the data comes from

  • ClinicalTrials.gov. The registry held 612,025 study records on November 17, 2026, by its own API's count. The API (version 2.0.5 that day) answers queries without a key and filters by status, lead sponsor class, phase and first-posted date, so a weekly list of new industry trials that are not yet recruiting takes minutes to pull.
  • CTIS, the EU Clinical Trials Information System. Its searchable public website went live on January 31, 2022 and shows the EU trial number, therapeutic area, sponsor details and recruitment and trial dates. Trials started before January 31, 2023 under the old directive sit on the EU Clinical Trials Register instead.
  • ReBEC, the Brazilian Clinical Trials Registry, an open-access platform for studies with human participants in Brazil, run jointly by the Ministry of Health, the Pan American Health Organization and Fiocruz.
  • Funding, hiring and leadership news for the sponsor side.
612,025Study records on ClinicalTrials.gov on November 17, 2026
21 daysLatest a US applicable trial can be registered after the first participant enrolls
January 31, 2023Trials started before this date under the old directive are on the EU Clinical Trials Register

Who decides

At a small or mid-size biotech, the head or VP of clinical operations picks the CRO, often with the chief medical officer, and the CEO signs. At larger sponsors, clinical outsourcing or vendor management runs the process and clinical operations sets the requirements. For site networks selling to CROs, the CRO's feasibility and site selection team decides which sites get the study, and study start-up decides how fast.

How to approach them

Name the trial: its registry number, indication, phase and the gap you can fill, such as patients in a region, sites not yet on the record or a therapeutic area team. Keep the first message to what the record tells you and ask about the country plan. A site network writing to a CRO should bring enrollment history for that indication, not a brochure.

From a new registration to a first approach
  1. 1New registrationNot yet recruiting, with no sites listed
  2. 2Who decidesThe head or VP of clinical operations
  3. 3First approachName the trial and the gap you fill
  4. 4The questionAsk about the country plan

ALTARA, an AI sales agent your team texts like a teammate in WhatsApp, iMessage, SMS, Slack or Microsoft Teams, watches funding rounds, hiring, leadership changes and trade shows, finds the decision-maker with a verified work email and drafts the message in the sender's voice. Email and LinkedIn outreach starts only for contacts someone on your team approved.

An example

Example built from a public record
Mighty Therapeutics, Inc. · Trial sites not yet listed
What changed

Registered a Phase 2/3 trial of bevemipretide ophthalmic solution in dry age-related macular degeneration, estimated at 300 participants, status not yet recruiting, no sites listed

Why now

An estimated November 2026 start with no sites on the record means countries and sites are still being chosen

Talk to

Head of clinical operations

Route

Email first, LinkedIn connection three days later

Source: ClinicalTrials.gov record NCT07927010 ·

FAQ

How do I find new clinical trials that have not started recruiting?

Query ClinicalTrials.gov for studies with the status "not yet recruiting", an industry lead sponsor and a recent first-posted date. Its API returns these without a key, with phase, estimated enrollment, start date and locations. Records with no locations listed matter most to site networks and CROs, because the sites are still being chosen.

When must a US clinical trial be registered?

Under 42 CFR 11.24, an applicable clinical trial must be registered no later than 21 calendar days after the first participant is enrolled. Many sponsors register earlier, which is what makes "not yet recruiting" records useful, but some appear only after recruitment starts. Watch status and location changes on existing records as well as new registrations.

Where are EU and Brazilian trials registered?

Trials run under the EU Clinical Trials Regulation are on CTIS, whose public website shows the sponsor, therapeutic area and recruitment and trial dates. Trials started before January 31, 2023 under the old directive are on the EU Clinical Trials Register. In Brazil, studies are registered on ReBEC, run by the Ministry of Health, PAHO and Fiocruz.

Who should a CRO contact at a small biotech?

Usually the head or VP of clinical operations, who owns vendor selection and the country plan, often together with the chief medical officer. At larger sponsors, clinical outsourcing or vendor management runs the process. Write about the specific trial, its indication and phase, and the gap you fill, not about your company in general.

Try it on your market.

The free 14-day trial gives you 100 credits, about 20 leads, no card. ALTARA opens to a few teams at a time: join the waitlist and we set you up, or use an invite link to start right away.

Ask an AI about ALTARA: ChatGPT Claude Perplexity
Sources
  1. ClinicalTrials.gov API, studies endpoint, read on 2026-11-17
  2. ClinicalTrials.gov API, version, read on 2026-11-17
  3. ClinicalTrials.gov API, database size statistics, read on 2026-11-17
  4. 42 CFR 11.24, When must clinical trial registration information be submitted?, Legal Information Institute, read on 2026-11-17
  5. Clinical Trials Information System (CTIS), European Medicines Agency, read on 2026-11-17
  6. Brazilian Clinical Trials Registry (ReBEC), read on 2026-11-17
  7. NCT07927010, ClinicalTrials.gov, read on 2026-11-17